📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Totient

1.1 - Company Overview

Totient Logo

Totient

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of AI-driven biotechnology leveraging tertiary lymphoid structures to identify novel tissue-specific antigens and develop matching high-affinity antibody therapeutics, using machine learning and immunoinformatics to pull critical insights from large, complex datasets.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Totient

Viracta Therapeutics Logo

Viracta Therapeutics

HQ: United States Website
  • Description: Provider of precision oncology therapies targeting virus-associated malignancies, including Nana-val (nanatinostat + valganciclovir) for relapsed/refractory EBV+ lymphoma (late-stage clinical) and recurrent/metastatic EBV+ solid tumors (early-stage clinical), alongside preclinical products for undisclosed indications and an expanded access policy for investigational treatments.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Viracta Therapeutics company profile →
Century Therapeutics Logo

Century Therapeutics

HQ: United States Website
  • Description: Provider of iPSC-derived allogeneic NK and T cell therapies for cancer and autoimmune diseases, including CNTY-101 targeting CD19-positive B-cell lymphomas (Phase 1 ELiPSE-1). Offers CRISPR-MAD7 mediated HDR gene editing, Allo-Evasion technology for immune evasion and repeat dosing, CAR and protein engineering, and common engineered iPSC progenitors to accelerate development.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Century Therapeutics company profile →
IDEC Pharmaceuticals Logo

IDEC Pharmaceuticals

HQ: United States Website
  • Description: Provider of therapy development targeting neurodegenerative, hematologic, and autoimmune diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full IDEC Pharmaceuticals company profile →
IO Biotech Logo

IO Biotech

HQ: Denmark Website
  • Description: Provider of immune-modulating cancer therapies built on its T-win technology, activating T cells against tumor and immune-suppressive cells. Offers IO102-IO103 T-win vaccines targeting IDO and PD-L1, used with anti-PD-1 therapy for metastatic melanoma, and runs Phase 2/3 trials with pembrolizumab in melanoma, lung, head and neck, and bladder cancers.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full IO Biotech company profile →
Lengo Therapeutics Logo

Lengo Therapeutics

HQ: United States Website
  • Description: Provider of biopharmaceutical solutions focused on discovering and developing cancer treatments, including AYVAKIT/AYVAKYT (avapritinib) for systemic mastocytosis and gastrointestinal stromal tumors with PDGFRA exon 18 mutations. Offers clinical trials, a U.S. patient support program for access and affordability, and a scientific platform to develop highly selective medicines for mast cell disorders and cancer.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Lengo Therapeutics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Totient

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Totient

2.2 - Growth funds investing in similar companies to Totient

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Totient

4.2 - Public trading comparable groups for Totient

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Totient

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Totient

What does Totient do?

Totient is a provider of AI-driven biotechnology leveraging tertiary lymphoid structures to identify novel tissue-specific antigens and develop matching high-affinity antibody therapeutics, using machine learning and immunoinformatics to pull critical insights from large, complex datasets.

Who are Totient's competitors?

Totient's competitors and similar companies include Viracta Therapeutics, Century Therapeutics, IDEC Pharmaceuticals, IO Biotech, and Lengo Therapeutics.

Where is Totient headquartered?

Totient is headquartered in United States.

How many employees does Totient have?

Totient has 1,000 employees 🔒.

When was Totient founded?

Totient was founded in 2010 🔒.

What sector and industry vertical is Totient in?

Totient is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Totient

Who are the top strategic acquirers in Totient's sector and industry

Top strategic M&A buyers and acquirers in Totient's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Totient?

Top strategic M&A buyers groups and sectors for Totient include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Totient's sector and industry vertical

Which are the top PE firms investing in Totient's sector and industry vertical?

Top PE firms investing in Totient's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Totient's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Totient's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Totient's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Totient include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Totient's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Totient?

The key public trading comparables and valuation benchmarks for Totient include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Totient for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Totient with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Totient's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Totient with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Totient's' sector and industry vertical?

Access recent funding rounds and capital raises in Totient's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Totient